GeNeuro: Recent Study Demonstrates the Strong Link Between SARS‑CoV‑2 Infection and HERV-W Activation in Hospitalized Psychotic Patients Seite 1

11.09.2023 - Regulatory News: GeNeuro (Euronext Paris: CH0308403085 - GNRO), a biopharmaceutical company developing treatments for neurodegenerative and autoimmune diseases, such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS) and the severe ... Seite 1

Related Keywords

Paris ,France General ,France ,Italy ,United States , ,Psychiatry Department Of The Cr ,Schizophrenia International Research Society ,Robert Yolken Johns Hopkins University ,Psychiatry Department ,Robert Yolken ,Johns Hopkins University ,Geneuro Porteur Chart ,Eneuro Porteur Kurs ,Eneuro Porteur Aktie ,